Differentially expressed genes in neurofibromatosis 1-associated neurofibromas and malignant peripheral nerve sheath tumors.
Neurofibromas represent one of the hallmarks of neurofibromatosis 1 (NF1) patients. Tumor progression of neurofibromas to malignant peripheral nerve sheath tumors (MPNST) is a frequent and life threatening complication. To learn more about processes involved in malignant transformation, we evaluated differential gene expression in plexiform neurofibroma and MPNST from the same NF1 patient. Suppression subtractive hybridization (SSH) yielded 133 differentially expressed genes confirmed by reverse Northern blotting. Virtual Northern blots were employed to validate 23 genes. To independently verify differential expression, immunohistochemical analyses with antibodies to matrix metalloproteinase 13 (MMP13), platelet-derived growth factor receptor alpha (PDGFRA) and fibronectin (FN1) were performed on 9 dermal and 9 plexiform neurofibromas and 16 MPNST from 19 NF1 patients. All three proteins proved to be up-regulated in MPNST. MMP13 expression was observed in 44% of MPNST but was absent in neurofibromas. PDGFRA was expressed in all tumors, but the number of cells expressing it was below 30% in neurofibromas and over 50% in MPNST. Likewise, FN1 was expressed in all tumors, but less than 30% of the cells in neurofibromas and more than 70% of the cells in MPNST exhibited antibody binding. Our data point to several genes not previously recognized to be differentially expressed, and provide a framework for future studies on progression-associated gene expression in low- and high-grade nerve sheath tumors.
Holtkamp
Nikola
N
Institute of Neuropathology, Charité, Humboldt University, Campus Virchow Klinikum, Augustenburgerplatz 1, 13353 Berlin, Germany.
Mautner
Victor-F
VF
Friedrich
Reinhard E
RE
Harder
Anja
A
Hartmann
Christian
C
Theallier-Janko
Agota
A
Hoffmann
Karl T
KT
von Deimling
Andreas
A
D000328:Adult; D015152:Blotting, Northern; D017364:Collagenases / Q000378:metabolism; D005260:Female; D005353:Fibronectins / Q000378:metabolism; D015870:Gene Expression; D006801:Humans; D006824:Hybridization, Genetic; D007150:Immunohistochemistry; D036341:Intercellular Signaling Peptides and Proteins; D008279:Magnetic Resonance Imaging; D053509:Matrix Metalloproteinase 13; D018317:Nerve Sheath Neoplasms / Q000150:complications / Q000235:genetics / Q000378:metabolism*; D009455:Neurofibroma / Q000150:complications / Q000235:genetics / Q000378:metabolism*; D009456:Neurofibromatosis 1 / Q000150:complications / Q000235:genetics / Q000378:metabolism*; D010388:Pelvis / Q000473:pathology; D010750:Phosphoproteins / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D017421:Sequence Analysis
D005353:Fibronectins; D036341:Intercellular Signaling Peptides and Proteins; C103312:PDAP1 protein, human; D010750:Phosphoproteins; D010982:Platelet-Derived Growth Factor; D017364:Collagenases; C507079:MMP13 protein, human; D053509:Matrix Metalloproteinase 13